Logo
x

Search

Subscribe Now

Onco360

Insights+: The US FDA New Drug Approvals in November 2021

Insights+: The US FDA New Drug Approvals in November 2021

  • December 16, 2021
Onco360's BESREMi (ropeginterferon alfa-2b-njft) Receives the US FDA’s Approval for the Treatment of Polycythemia Vera

Onco360's BESREMi (ropeginterferon alfa-2b-njft) Receives the US FDA’s Approval for the Treatment of Polycythemia Vera

  • November 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.